Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Vosaroxin – Treatment for Myeloid Leukaemia

Drug

Vosaroxin

Company

Sunesis Pharmaceuticals

Therapy Class

Topoisomerase II inhibitor

Product Description

Anticancer Quinolone Derivative

Current Indications

Acute Myeloid Leukaemia (AML) and platinum-resistance ovarian cancer

Market Sector

Oncology

Development Status

Phase III
Expand

Go Top